RXI PHARMACEUTICALS CORP (RXII) earnings
Quarterly and annual RXII reports and results, each read against the price at its own news timestamp. Back to the RXII overview →
No RXII earnings events in the measured window.
Nothing matched in the current window — the RXII overview has every event we measure for this name.
Get an email when RXII moves on news →Keep exploring
More RXII: analyst actions → · SEC filings → · RXII overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| AKERS BIOSCIENCES INC COMMON S (AKER) | 478 | -0.87% | 33% |
| Axon Enterprise, Inc. (AXON) | 478 | -0.04% | 48% |
| Rhythm Pharmaceuticals, Inc. (RYTM) | 477 | -0.11% | 46% |
| Ascendis Pharma A/S - Ordinary Share (ASND) | 474 | -0.08% | 48% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.